Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Zhonghua Wai Ke Za Zhi ; 60(12): 1063-1068, 2022 Dec 01.
Article in Chinese | MEDLINE | ID: mdl-36480873

ABSTRACT

Objective: To examine the application effect of the modified wire-loop snare technique in retrieving severely tilted inferior vena cava filters (IVCF). Methods: The clinical data of 18 patients (12 males and 6 females, aged (62.1±13.1) years (range: 29 to 78 years)) who underwent the modified wire-loop snare technique to retrieve IVCF at the Affiliated Hospital of Qingdao University, Qingdao Eighth People's Hospital, and Jimo District Hospital of Traditional Chinese Medicine from November 2017 to April 2022 were retrospectively analyzed. The applied filters included drum-type filters (OptEase in 7 cases, Aegisy in 2 cases) and conical filters (Celect in 6 cases and Denali in 3 cases). Preoperative CT angiography and intraoperative digital subtraction angiography showed that the filter was severely tilted and the hook was covered by hyperplastic intima of the vena cave vein. A modified wire-loop snare technique was used to retrieve drum-type filters and conical filters via femoral and jugular vein approaches, respectively. After successful puncture, the long sheath was placed, the 4 F (1 F≈0.33 mm) vertebral catheter and a snare were inserted through the long sheath, and the 5 F pigtail catheter was inserted simultaneously to guide a 0.035 inch soft guide-wire (260 cm in length) to pass through the top of the filter and turning back. The tip of the soft guide-wire was snared by the vertebral catheter and pulled out of the sheath. The 4 F vertebral catheter was inserted following the tip of the guide-wire to form a wire-loop using the vertebral catheter and the pigtail catheter. After fixing the tip and tail of the soft guide-wire in vitro, the long sheath was pushed forward to cut the hyperplastic intima and the hook was pulled away from the vena cava wall to retrieve the filter under the support of two catheters. Results: The filters were successfully retrieved in 17 cases, the operation time was (25.5±8.7) minutes (range: 15 to 45 minutes), no complication occured. The hook of one filter (Celect) penetrated out of the vena vava wall and the wire-loop could not pull the hook back into the vena cava. Then the filter was removed by laparotomy. Conclusion: The modified wire-loop snare technique could retrieve the severely tilted retrivable drum-type filters and conical filters, even when serve adhesion exists between the filter and the vena cava wall.


Subject(s)
Vena Cava Filters , Humans , Retrospective Studies
2.
Integr Cancer Ther ; 21: 15347354221074349, 2022.
Article in English | MEDLINE | ID: mdl-35112579

ABSTRACT

OBJECTIVE: Research is needed to guide the timing and safety of rehabilitation (physical and occupational therapy) in patients with acute deep venous thrombosis (DVT) that is untreated due to contraindications. CASE DESCRIPTION: A 21-year-old man with Hodgkin lymphoma was admitted to the hospital for neutropenic fever. He developed gastrointestinal bleeding, diffuse alveolar hemorrhage, and bilateral lower-extremity DVT. He was not a candidate for chemical anticoagulation or placement of an inferior vena cava filter owing to thrombocytopenia. Rehabilitation was initially deferred because of concern that the thrombus could travel to the lungs, causing a pulmonary embolism. Rehabilitation was, however, started 4 days after the initial diagnosis of lower-extremity DVT to assess functional mobility and activities of daily living skills to prepare for discharge from the hospital. RESULTS: The patient experienced no bleeding events during rehabilitation, and his acute, untreated DVT did not propagate based on clinical assessment. His Activity Measure for Post-Acute Care (AM-PAC) "6 Clicks" Basic Mobility score improved from 30.25 to 35.55 over the period of 11 days while he received rehabilitation. CONCLUSION: Despite having an acute bilateral lower-extremity DVT that was untreatable owing to thrombocytopenia, the patient successfully participated in rehabilitation and improved his physical functional status without an adverse event. Untreated acute venous thromboembolism in the setting of recent history of major bleeding raise concerns about physical activity restrictions. It is critical to consider both the risks and benefits of mobilizing patients and prescribing exercises in patients with these conditions.


Subject(s)
Neoplasms , Thrombocytopenia , Vena Cava Filters , Venous Thrombosis , Activities of Daily Living , Adult , Humans , Male , Neoplasms/complications , Retrospective Studies , Vena Cava Filters/adverse effects , Venous Thrombosis/etiology , Venous Thrombosis/therapy , Young Adult
4.
Am J Hematol ; 94(11): 1176-1184, 2019 11.
Article in English | MEDLINE | ID: mdl-31379000

ABSTRACT

Venous thromboembolism (VTE) is a common cause of morbidity and mortality among patients with multiple myeloma (MM). The International Myeloma Working Group (IMWG) developed guidelines recommending primary thromboprophylaxis, in those identified at high-risk of VTE by the presence of risk factors. The National Comprehensive Cancer Network (NCCN) has adopted these guidelines; however, they lack validation. We sought to develop and validate a risk prediction score for VTE in MM and to evaluate the performance of the current IMWG/NCCN guidelines. Using 4446 patients within the Veterans Administration Central Cancer Registry, we used time-to-event analyses to develop a risk score for VTE in patients with newly diagnosed MM starting chemotherapy. We externally validated the score using the Surveillance, Epidemiology, End Results (SEER)-Medicare database (N = 4256). After identifying independent predictors of VTE, we combined the variables to develop the IMPEDE VTE score (Immunomodulatory agent; Body Mass Index ≥25 kg/m2 ; Pelvic, hip or femur fracture; Erythropoietin stimulating agent; Dexamethasone/Doxorubicin; Asian Ethnicity/Race; VTE history; Tunneled line/central venous catheter; Existing thromboprophylaxis). The score showed satisfactory discrimination in the derivation cohort, c-statistic = 0.66. Risk of VTE significantly increased as score increased (hazard ratio 1.20, P = <.0001). Within the external validation cohort, IMPEDE VTE had a c-statistic of 0.64. For comparison, when evaluating the performance of the IMWG/NCCN guidelines, the c-statistic was 0.55. In summary, the IMPEDE VTE score outperformed the current IMWG/NCCN guidelines and could be considered as the new standard risk stratification for VTE in MM.


Subject(s)
Multiple Myeloma/complications , Venous Thromboembolism/etiology , Aged , Anticoagulants/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Body Mass Index , Catheterization, Central Venous/adverse effects , Combined Modality Therapy , Comorbidity , Databases, Factual , Dexamethasone/administration & dosage , Dexamethasone/adverse effects , Female , Follow-Up Studies , Glomerular Filtration Rate , Hematopoietic Stem Cell Transplantation , Humans , Male , Medicare , Middle Aged , Multiple Myeloma/drug therapy , Multiple Myeloma/therapy , Retrospective Studies , Risk Assessment/methods , Risk Factors , SEER Program , United States , Vena Cava Filters , Venous Thromboembolism/prevention & control
6.
Heart Rhythm ; 16(6): 873-878, 2019 06.
Article in English | MEDLINE | ID: mdl-30590192

ABSTRACT

BACKGROUND: The presence of inferior vena cava filters (IVCFs) has been considered a relative contraindication to electrophysiology (EP) procedures that require transfemoral venous placement of multiple catheters and/or long sheaths. There are inadequate data related to complex EP procedures in this population. OBJECTIVE: The purpose of this study was to describe the experience of a single high-volume center with respect to complex EP procedures in patients with IVCFs. METHODS: Patients with IVCFs undergoing complex EP procedures between 2004 and 2018 were identified. Clinical characteristics, IVCF type, procedural findings, and complications were analyzed. RESULTS: Fifty complex ablation procedures were performed in 40 patients (mean age 63.8 ± 10.9 years; 68% men). The mean IVCF dwell time was 69.1 ± 19.1 months, and 48 patients (96%) were on chronic oral anticoagulation. Procedures included ablation of atrial fibrillation (n = 21), ventricular tachycardia (n = 20), supraventricular tachycardia (n = 3), cavotricuspid isthmus flutter (n = 3), supraventricular tachycardia and cavotricuspid isthmus flutter (n = 1), and transvenous lead extraction (n = 3). Twenty procedures included quadripolar catheters (mean 1.4 ± 0.75), and 33 procedures involved deflectable decapolar catheters (mean 1.7 ± 0.47). Long sheaths were used in 35 cases (mean 1.63 ± 0.49) and intracardiac echocardiography in 38. In 4 cases (involving 3 patients), the IVCF was occluded and could not be crossed. There were no procedural complications related to the IVCF. CONCLUSION: The substantial majority of IVCFs in patients presenting for complex EP procedures were patent and easily crossed under fluoroscopic guidance. The presence of an IVCF should not discourage operators from performing procedures that require transfemoral deployment of multiple catheters and/or sheaths.


Subject(s)
Arrhythmias, Cardiac/surgery , Cardiac Catheterization , Catheterization, Peripheral , Femoral Vein , Vena Cava Filters , Venous Thrombosis , Anticoagulants/therapeutic use , Arrhythmias, Cardiac/classification , Cardiac Catheterization/adverse effects , Cardiac Catheterization/instrumentation , Cardiac Catheterization/methods , Catheter Ablation/methods , Catheterization, Peripheral/adverse effects , Catheterization, Peripheral/instrumentation , Catheterization, Peripheral/methods , Catheters , Device Removal/methods , Electrophysiologic Techniques, Cardiac/methods , Feasibility Studies , Female , Femoral Vein/diagnostic imaging , Femoral Vein/surgery , Humans , Male , Middle Aged , Outcome and Process Assessment, Health Care , Surgery, Computer-Assisted/methods , Venous Thrombosis/drug therapy , Venous Thrombosis/surgery
7.
Ann Vasc Surg ; 51: 284-297, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29655810

ABSTRACT

BACKGROUND: Inferior vena cava filters (IVCFs) are indicated for therapeutic and prophylactic treatment of venous thromboembolism in patients when anticoagulation has failed or is contraindicated. Retrievable IVCFs are not always retrieved despite clinical recommendations. The purpose of this review is to compare results in the literature regarding interventions and to improve IVCF retrieval rates. METHODS: Articles were identified via the search terms "vena cava filters" and "inferior vena cava filters" in conjunction with "retrieval." Searches were repeated in MEDLINE/PubMed, Google Scholar, and Cochrane database. Exclusion criteria included duplicates, misidentified subject matter, study period before 2008, and lack of control group. Two independent reviewers screened key elements in the identified manuscripts, including the targeted intervention population, study design, IVCF retrieval rates, and other outcomes. A third reviewer corroborated results and consolidated findings. RESULTS: Seventeen articles were identified for review. Of these, 12 were physician-targeted interventions, and 8 were patient-targeted interventions (3 studies included both). IVCF retrieval rates varied substantially for each study, but all reviewed studies reported improvement in retrieval rate following intervention. Only 5 studies reported decreased IVCF indwell times in intervention groups. Reported complication rates from IVCF retrievals were low, ranging from 0 to 2%. CONCLUSIONS: IVCF retrieval rates were improved by all interventions in the reviewed studies. Findings suggest that IVCF retrieval rates can be best improved by tracking patients typically lost to follow-up. Literature suggests that successful tracking requires an individual or team of individuals who have been assigned dedicated clinical responsibility for coordinating care following IVCF placement.


Subject(s)
Device Removal/methods , Prosthesis Implantation/instrumentation , Vena Cava Filters , Vena Cava, Inferior , Aftercare , Delivery of Health Care, Integrated , Device Removal/adverse effects , Humans , Patient Care Team , Prosthesis Design , Prosthesis Implantation/adverse effects , Time Factors , Treatment Outcome , Vena Cava, Inferior/diagnostic imaging
8.
Angiol Sosud Khir ; 23(3): 62-67, 2017.
Article in Russian | MEDLINE | ID: mdl-28902815

ABSTRACT

Balloon angioplasty and stenting have increasingly been gaining widespread application for treatment of post-thrombotic alterations in the system of the vena cava. Endovascular ultrasonographic examination makes it possible with the utmost degree of reliability to determine both the extension and degree of the narrowing of venous segments, thus proving a possibility of choosing a venous stent of an appropriate diameter. Restoration of an adequate venous lumen leads to normalization of blood flow and elimination of venous hypertension. However, unsolved as yet remains the problem concerning proper management of post-thrombotic obstructions of the inferior vena cava at the level of a cava filter. Owing to a wide variety of configurations of cava filters to deploy, there are no common approaches to elimination of such obstruction. Presented herein is a clinical case report regarding successful endovascular treatment of a patient diagnosed with post-thrombotic disease secondary to endured thrombosis. The findings of both phlebography and endovascular ultrasonographic examination made it possible to diagnose obstruction of the left common iliac vein, external iliac vein, and inferior vena cava to the level of the cava filter previously deployed. In the segment of the inferior vena cava at the level of the cava filter also revealed was a pronounced luminal narrowing exceeding 90% of its diameter. We carried out stenting of the common and external iliac veins, inferior vena cava, and the cava filter. Swelling of the left leg subsided spontaneously within 2 weeks and the first postoperative month was accompanied by gradual disappearance of the previously existing feeling of heaviness in the lower limbs and a dramatic decrease in fatigue by the end of the working day.


Subject(s)
Angioplasty, Balloon , Iliac Vein , Postthrombotic Syndrome , Stents , Vena Cava Filters/adverse effects , Vena Cava, Inferior , Venous Thrombosis/surgery , Adult , Angioplasty, Balloon/instrumentation , Angioplasty, Balloon/methods , Constriction, Pathologic/diagnosis , Constriction, Pathologic/pathology , Constriction, Pathologic/physiopathology , Constriction, Pathologic/surgery , Endovascular Procedures/methods , Humans , Iliac Vein/diagnostic imaging , Iliac Vein/surgery , Male , Phlebography/methods , Postthrombotic Syndrome/diagnosis , Postthrombotic Syndrome/pathology , Postthrombotic Syndrome/physiopathology , Postthrombotic Syndrome/surgery , Treatment Outcome , Ultrasonography, Interventional/methods , Vena Cava, Inferior/diagnostic imaging , Vena Cava, Inferior/pathology , Vena Cava, Inferior/surgery , Venous Thrombosis/complications
11.
Ultrasound Med Biol ; 41(4): 929-35, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25701518

ABSTRACT

Inferior vena cava filters (IVCFs) have been used clinically for approximately 45 y, but only a few studies of these devices have involved intensive care unit (ICU) patients who were critically ill and had multiple-organ dysfunction or were otherwise too unstable for transport. The purpose of this research was to assess the tolerability and efficacy of bedside ultrasound-guided IVCF placement in ICU patients. A retrospective analysis of both bedside ultrasound-guided and X-ray-guided ICVF placement was performed from November of 2011 to August of 2013. The total success rate for ultrasound-guided IVCF placement was 93.4%, which included a 96.0% success rate in 25 ICU patients with an average age of 69.46 y. Six-month follow-up studies revealed no significant differences in long-term complications between the ultrasound- and X-ray-guided groups. IVCFs may be safely implanted under ultrasound guidance in a monitored ICU environment. Our conclusion is that patients should be fasting and should receive an enema and that pre-operative surface marking and dynamic monitoring should be employed. Further research is needed to develop specific ultrasound guidelines.


Subject(s)
Critical Care/methods , Ultrasonography, Interventional/methods , Vena Cava Filters , Vena Cava, Inferior/diagnostic imaging , Venous Thrombosis/therapy , Aged , Critical Illness , Female , Follow-Up Studies , Humans , Intensive Care Units , Male , Middle Aged , Retrospective Studies , Treatment Outcome
12.
JAMA ; 311(7): 717-28, 2014 Feb 19.
Article in English | MEDLINE | ID: mdl-24549552

ABSTRACT

IMPORTANCE: Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common, potentially lethal condition with acute morbidity. OBJECTIVE: To review the etiology of VTE and the 3 phases of VTE treatment: acute (first 5-10 days), long-term (from end of acute treatment to 3-6 months), and extended (beyond 3-6 months). EVIDENCE REVIEW: Cochrane reviews, meta-analyses, and randomized controlled trials, as well as other clinical trials for topics not covered by the former, were reviewed. Literature searches using broad terms were used to find meta-analyses published in the last 15 years. The ninth edition of the American College of Chest Physicians Antithrombotic Therapy Guidelines was used to supplement the literature search. Guidelines from specialty organizations were consulted when relevant. The Canadian Agency for Drugs and Technologies in Health was searched for relevant cost-effectiveness studies. We also searched our own literature database of 8386 articles for relevant research. FINDINGS: Low-molecular-weight heparin (LMWH) along with with vitamin K antagonists and the benefits and proven safety of ambulation have allowed for outpatient management of most cases of DVT in the acute phase. Development of new oral anticoagulants further simplifies acute-phase treatment and 2 oral agents can be used as monotherapy, avoiding the need for LMWH. Patients with PE can also be treated in the acute phase as outpatients, a decision dependent on prognosis and severity of PE. Thrombolysis is best reserved for severe VTE; inferior vena cava filters, ideally the retrievable variety, should be used when anticoagulation is contraindicated. In general, DVT and PE patients require 3 months of treatment with anticoagulants, with options including LMWH, vitamin K antagonists, or direct factor Xa or direct factor IIa inhibitors. After this time, decisions for further treatment are based on balancing the risk of VTE recurrence, determined by etiology of the VTE (transient risk factors, unprovoked or malignancy associated), against the risk of major hemorrhage from treatment. Better prediction tools for major hemorrhage are needed. Experience with new oral anticoagulants as acute, long-term, and extended therapy options is limited as yet, but as a class they appear to be safe and effective for all phases of treatment. CONCLUSIONS AND RELEVANCE: The mainstay of VTE treatment is anticoagulation, while interventions such as thrombolysis and inferior vena cava filters are reserved for limited circumstances. Multiple therapeutic modes and options exist for VTE treatment with small but nonetheless important differential effects to consider. Anticoagulants will probably always increase bleeding risk, necessitating tailored treatment strategies that must incorporate etiology, risk, benefit, cost, and patient preference. Although great progress has been made, further study to understand individual patient risks is needed to make ideal treatment decisions.


Subject(s)
Anticoagulants/therapeutic use , Venous Thromboembolism/drug therapy , Anticoagulants/adverse effects , Hemorrhage/chemically induced , Hemorrhage/prevention & control , Humans , Meta-Analysis as Topic , Randomized Controlled Trials as Topic , Thrombolytic Therapy , Vena Cava Filters
13.
Aging Clin Exp Res ; 26(1): 73-5, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23949974

ABSTRACT

The incidence of deep vein thrombosis (DVT) and pulmonary embolism has been increasing in the elderly because of hypercoagulability associated with aging. Age has also been identified as an independent risk factor for bleeding complications related to anticoagulation therapy. Inferior vena cava filters could be used as alternatives to anticoagulant therapy for the prevention of pulmonary embolism when anticoagulation is either contraindicated or ineffective. Here, we report two geriatric patients who had documented acute DVT and in whom inferior vena caval filter was used because of the patients have a contraindication to use an anticoagulation.


Subject(s)
Anticoagulants/therapeutic use , Vena Cava Filters , Venous Thrombosis/prevention & control , Aged , Female , Humans , Male , Pulmonary Embolism/prevention & control
14.
Injury ; 44(12): 1710-20, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23816168

ABSTRACT

The management of thromboprophylaxis in patients with pelvic and acetabular fractures remains a highly controversial topic within the trauma community. Despite anticoagulation, venous thromboembolism (VTE) remains the most common cause of surgical morbidity and mortality in this high-risk patient group. Although various thromboprophylactic regimes are employed, evidence relating to the most effective method remains unclear. Controversies surrounding screening, the use of prophylactic inferior vena cava filters (IVCF) and chemothromboprophylaxis in polytraumatised patients, particularly those with pelvic and acetabular fractures, form the basis of considerable debate. With the absence of a well-designed clinical trial and the presence of ongoing controversies within the literature, this review will explore current treatment options available to trauma surgeons and highlight differing scientific opinions, providing an update on the role of screening and current available preventative measures. We cover existing as well as recent advances in chemical thromboprophylactic agents and discuss external mechanical compression devices, the usefulness of serial duplex ultrasonography and the role of extended chemothromboprophylaxis on discharge. The evidence behind prophylactic IVCF is also considered, along with reported complication profiles. We conclude with a proposed protocol for use in major trauma centres, which can form the basis of local policy for the prevention of VTE in trauma patients with pelvic and acetabular fractures.


Subject(s)
Acetabulum/injuries , Anticoagulants/therapeutic use , Fractures, Bone/complications , Pelvis/injuries , Venous Thromboembolism/prevention & control , Aspirin/therapeutic use , Benzimidazoles/therapeutic use , Coumarins/therapeutic use , Dabigatran , Fondaparinux , Heparin/therapeutic use , Humans , Mass Screening/methods , Morpholines/therapeutic use , Multiple Trauma/complications , Polysaccharides/therapeutic use , Pulmonary Embolism/prevention & control , Pyrazoles/therapeutic use , Pyridones/therapeutic use , Risk Assessment , Rivaroxaban , Thiophenes/therapeutic use , Vena Cava Filters , beta-Alanine/analogs & derivatives , beta-Alanine/therapeutic use
15.
S Afr Med J ; 103(4 Pt 2): 261-7, 2013 Feb 15.
Article in English | MEDLINE | ID: mdl-23547704

ABSTRACT

BACKGROUND: Pharmacological prophylactic anticoagulation in many countries, including South Africa, is under-prescribed. This has resulted in unacceptable rates of morbidity and mortality. METHOD: The Southern African Society of Thrombosis and Haemostasis held a meeting to update the previous guideline and review new literature including guidelines from other societies. The following specialties were represented on the committees: anaesthetics, cardiology, clinical haematology, critical care, obstetrics and gynaecology, haematopathology, internal medicine, neurology, orthopaedic surgery and pulmonology. A draft document was presented at the meeting, which was then revised by consensus agreement. To avoid local bias, the guideline was adjudicated by recognised international external experts. RESULTS AND CONCLUSION: A concise, practical updated guideline for thromboprophylaxis and treatment in medical and surgical patients has been produced for South African conditions. It is hoped that this guideline will continue to improve anticoagulation practice in this country, which we believe will directly benefit patient outcomes.


Subject(s)
Anticoagulants , Hemorrhage , Preoperative Care/methods , Secondary Prevention/methods , Vena Cava Filters , Venous Thromboembolism , Anticoagulants/administration & dosage , Anticoagulants/adverse effects , Benzimidazoles/administration & dosage , Benzimidazoles/adverse effects , Chemoprevention/methods , Dabigatran , Disease Management , Dose-Response Relationship, Drug , Drug Delivery Systems/methods , Drug Monitoring/methods , Drug Substitution/methods , Hemorrhage/chemically induced , Hemorrhage/prevention & control , Hemorrhage/therapy , Heparin, Low-Molecular-Weight/administration & dosage , Heparin, Low-Molecular-Weight/adverse effects , Humans , International Normalized Ratio , Morpholines/administration & dosage , Morpholines/adverse effects , Risk Assessment , Risk Factors , Rivaroxaban , Thiophenes/administration & dosage , Thiophenes/adverse effects , Time Factors , Venous Thromboembolism/classification , Venous Thromboembolism/diagnosis , Venous Thromboembolism/prevention & control , Venous Thromboembolism/therapy , beta-Alanine/administration & dosage , beta-Alanine/adverse effects , beta-Alanine/analogs & derivatives
16.
Emerg Med Pract ; 14(12): 1-22, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23218203

ABSTRACT

Each year in the United States, up to 900,000 individuals will suffer from acute pulmonary embolism, resulting in an estimated 200,000 to 300,000 hospital admissions. Despite decades of research on the topic, the diagnosis remains elusive in many situations and the fatality rate remains significant. This issue presents a review of the current evidence guiding the emergency medicine approach to the diagnosis and treatment of pulmonary embolism. Key to this approach is the concept of risk stratification: using factors from the history and physical examination, plus ancillary tests, to guide clinical decision making. The pathophysiology of pulmonary embolism and decision-support tools are reviewed, and emergency department management strategies are described.


Subject(s)
Pulmonary Embolism/diagnosis , Pulmonary Embolism/therapy , Critical Pathways , Electrocardiography , Emergency Medicine , Humans , Male , Middle Aged , Physical Examination , Pulmonary Embolism/physiopathology , Risk Assessment , Sensitivity and Specificity , Severity of Illness Index , Vena Cava Filters , Venous Thromboembolism/physiopathology , Ventilation-Perfusion Ratio
17.
Cardiovasc Intervent Radiol ; 34 Suppl 2: S321-3, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21140262

ABSTRACT

Symptomatic penetration of the inferior vena cava (IVC) wall reportedly occurs in 0.3% of patients in whom a filter has been implanted, and it causes injury to the adjacent structures (Bogue et al. in Pediatr Radiol 39(10):1110-1113, 1; Brzezinski et al. in Burns 32(5):640-643, 2). We succeeded in the endovascular repair of perforation of the IVC wall occurring during the retrieval of a penetrated Gunther tulip vena cava filter (Cook, Bjaeverskov, Denmark) after long-term implantation.


Subject(s)
Aorta, Abdominal , Device Removal/adverse effects , Endovascular Procedures/methods , Foreign-Body Migration/therapy , Kidney Pelvis/injuries , Vascular System Injuries/therapy , Vena Cava Filters , Vena Cava, Inferior/injuries , Aged , Embolization, Therapeutic/instrumentation , Enbucrilate/administration & dosage , Endometrial Neoplasms/surgery , Endovascular Procedures/instrumentation , Ethiodized Oil/administration & dosage , Female , Foreign-Body Migration/diagnosis , Humans , Ovarian Neoplasms/surgery , Phlebography , Postoperative Complications/diagnosis , Postoperative Complications/prevention & control , Pulmonary Embolism/prevention & control , Tissue Adhesives , Tomography, X-Ray Computed , Vascular System Injuries/diagnosis
18.
Injury ; 40 Suppl 4: S90-4, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19895959

ABSTRACT

A review of current literature discussing thromboprophylaxis in the multiple-trauma patient to provide insight on the type of treatment and its duration of use. AMEDLINE search was conducted in May 2009 using keywords associated with thromboprophylactic measures in multiple-trauma patient care, including inferior vena cava (IVC) filters, mechanical-compression devices and anticoagulants. Abstracts were evaluated for relevance to this study and full-text articles were then examined individually. Fourteen full text articles were evaluated including guidelines published by the American College of Chest Physicians (ACCP) and the Eastern Association for the Surgery of Trauma (EAST) and other studies dealing with multiple-trauma patients, including those in hip-fracture surgery, lower-leg trauma and head trauma. Limited research has been performed for the multiple-trauma patient and recommendations regarding the type of treatment and its duration of use cannot be suggested beyond what has been extrapolated from existing trauma and major surgery patients. IVC filters, mechanical compression devices and anticoagulants therefore remain the standard, but their duration of use in the multiple-trauma patient is not well described. New oral anticoagulants that inhibit factor Xa or thrombin directly show promising qualities but have not been evaluated for multiple-trauma applications. Therefore, optimal thromboprophylaxis and its duration after multiple trauma is largely based on rational, clinical decision making on a case-by-case basis.


Subject(s)
Anticoagulants/therapeutic use , Heparin/therapeutic use , Multiple Trauma/drug therapy , Thromboembolism/prevention & control , Clinical Trials, Phase III as Topic , Device Removal , Factor Xa Inhibitors , Fondaparinux , Humans , Intermittent Pneumatic Compression Devices , Morpholines/therapeutic use , Multiple Trauma/complications , Polysaccharides/therapeutic use , Practice Guidelines as Topic , Rivaroxaban , Thiophenes/therapeutic use , Thromboembolism/etiology , Time Factors , Vena Cava Filters
19.
Heart Rhythm ; 2(1): 15-8, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15851258

ABSTRACT

OBJECTIVES: The purpose of this study was to evaluate the transfemoral venous approach for electrophysiologic interventions in patients with inferior vena cava filters. BACKGROUND: Reports have detailed complications associated with obtaining central venous access in patients with inferior vena cava filters. Accordingly, electrophysiologic interventions have been modified or deferred altogether in such patients. METHODS: Patients requiring interventions with a transfemoral approach who were at least 3 months post filter insertion underwent fluoroscopically guided insertion and withdrawal of electrode catheters with appropriate follow-up. RESULTS: Five patients underwent successful pacing, electrophysiologic study, or radiofrequency ablation using one to three catheters, with no complications attributable to filter placement. CONCLUSIONS: Transfemoral electrophysiologic interventions can be safely undertaken across vena cava filters provided appropriate precautions are taken.


Subject(s)
Catheter Ablation , Electrophysiologic Techniques, Cardiac , Vena Cava Filters , Aged , Aged, 80 and over , Cardiac Pacing, Artificial , Female , Femoral Vein , Fluoroscopy , Humans , Male , Vena Cava, Inferior
SELECTION OF CITATIONS
SEARCH DETAIL